Searched for
PHARMA GIANT LUPIN
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...- GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy genericsIndian drug makers are launching affordable generic Semaglutide, the active ingredient in popular weight-loss drugs. Sun Pharma, Lupin, and...
- GST department initiates inspection and search ops at Lupin's officeMaharashtra's Goods & Services Tax Department has initiated inspection and search proceedings at Lupin's registered office. The pharmaceuti...
- IRFC, MRF among 8 midcap stocks which hit new 52-week high on ThursdayAugust 3 witnessed a remarkable surge in the BSE MidCap segment as several stocks hit new 52-week highs, displaying strong bullish momentum...
- Lupin, Exide Industries among 6 BSE mid cap stocks approaching 52-week highInvestors are eyeing BSE Midcap stocks that are approaching their 52-week high levels, including Mahindra & Mahindra Financial Services, Ex...
- No Chinese supply threat for drug companies, but scaling Great Wall is tough“The concerns over supply of Chinese raw material proved to be ill-founded,” Nilesh Gupta, managing director of Lupin, told ET.
- Lupin to train over 1,000 graduates for pharma industryMumbai-headquartered Lupin has estimated that by the year 2020 they would be spending almost Rs 20 crore on this programme.
- Aurobindo, Dr Reddy's Laboratories frontrunners to buy out bankrupt Orchid PharmaOrchid was on the Reserve Bank of India's second list of 28 defaulters that had to be referred to the NCLT before December 31 if no resolut...
- Lupin, Cipla, other top drugmakers in fray for Novartis’ brandsThe Novartis portfolio includes top-selling brand TOBI Podhaler, a drug prescribed for symptomatic relief to patients suffering from cystic...
- GAVIS Pharma LLC looking to exit Bengaluru-based Wintac LtdGavis Pharma LLC is now exploring options to exit its listed Indian arm. Wintac Ltd was not part of the 2015 deal struck between Lupin & Ga...
- TCS, Infosys in Forbes India 'Super 50' list; Tata Motors, HUL droppedThe list, in its second year, also features 14 newcomers, including Infosys, Maruti Suzuki, Bharat Forge, Alembic Pharma, Gillette India, H...
- Lupin eyes UK pharma company Sinclair for $500 millionThe skin-focused pharma company, owned by a group of private equity investors, has asked investment bank NM Rothschild to help find a buyer...
- MSCI to add 8 new companies including Lupin, Bharti Infratel; Reliance Infrastructure to be removedThe other companies which would be added to the index include Eicher Motors, Bharat Forge, Container Corp of India, Marico, Shree Cement an...
- MSCI adds 8 new stocks to India Index; drops Reliance InfraEight companies, including Bharti Infratel, Eicher Motors, Lupin and Bharat Forge will be added to MSCI India Index, while Reliance Infrast...
- Wockhardt extends rally, up 17% intraday; doubles investors wealth in 3 monthsWockhardt has been in an uptrend since the beginning of the year surprising expectations of analysts but growth outlook still remains a con...
- Tata Motors top Indian company for R&D, pips RIL & Infosys: European CommissionAmong Indian firms, Tata Motors is followed by IT firms Prithvi Information and Polaris, state-run BHEL and M&M in the top-five.
- Japan's Takeda eyes Lupin, Cipla pharma business; shares surge in morning tradeShares of drug firms Cipla and Lupin surged after news reports surfaced that Takeda Pharmaceutical Co, is in talks to buy either of their p...
- Japan's Takeda eyes Lupin, Cipla pharma businessTakeda, Japan's largest pharmaceutical firm, has begun talks with two of India's biggest companies for purchasing either of their pharma bu...
- Not many Indian pharma cos are left for saleIn an interview with ET, Lupin's group president Shakti Chakraborty says recent acquisitions defied logic.
- Pfizer charges Sun with another patent violationA legal battle between Pfizer and Sun Pharmaceutical has escalated.
Load More
